Home General Physiology and Biophysics 2017 General Physiology and Biophysics Vol.36, No.5, p.487–499, 2017

Journal info


Founded: 1982
ISSN 1338-4325 (online)
ISSN 0231-5882 (print)
Published in English,
6 times per year

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

General Physiology and Biophysics Vol.36, No.5, p.487–499, 2017

Title: The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition
Author: Monika Kmeťová Sivoňová, Jana Jurečeková, Zuzana Tatarková, Peter Kaplán, Lucia Lichardusová, Jozef Hatok
Abstract: Abstract. Androgens play an important role during the development of both normal prostate epithelium and prostate cancer and variants of genes involved in androgen metabolism may be related to an increased risk of prostate disease. Cytochrome P450 17α-hydroxylase/17,20-lyase (CYP17A1) is a key regulatory enzyme in the steroidogenic pathway; it catalyses both 17α-hydroxylase and 17,20-lyase activities and is essential for the production of both androgens and glucocorticoids. In this review, we focus on the structure and enzymatic activity of CYP17A1 and the mechanism of modulation of CYP17A1 activities. We discuss the relationship between common genetic variations in CYP17A1 gene and prostate cancer risk and the main effects of these variations on the prediction of susceptibility and clinical outcomes of prostate cancer patients. The mechanism of action, the efficacy and the clinical potential of CYP17A1 inhibitors in prostate cancer are also summarized.
Keywords: CYP17A1 — Steroid 17 alpha-hydroxylase/17,20-lyase — CYP17A1 polymorphisms — CYP17A1 inhibitors — Prostate cancer
Published online: 17-Nov-2017
Year: 2017, Volume: 36, Issue: 5 Page From: 487, Page To: 499
doi:10.4149/gpb_2017024


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.